Aldeyra Therapeutics Inc (ALDX) stock has risen 29.13% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ALDX stock a score of 67 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 90. In addition to the average rating from Wall Street analysts, ALDX stock has a mean target price of 25.833. This means analysts expect the stock to rise 271.16% over the next 12 months. ALDX's rank also includes a short-term technical score of 63. The long-term technical score for ALDX is 49.
What's Happening with ALDX Stock Today
Aldeyra Therapeutics Inc (ALDX) stock has risen 0.94% while the S&P 500 has risen 0.03% as of 10:12 AM on Wednesday, Dec 16. ALDX has risen $0.07 from the previous closing price of $6.89 on volume of 95,160 shares. Over the past year the S&P 500 is higher by 15.76% while ALDX has risen 29.13%. ALDX lost -$1.30 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Aldeyra Therapeutics Inc (ALDX) Stock.
